Skip to main content

Table 3 Summary of the historical inputs and estimates for the HCV population in the base case

From: Modelling the impact of improving screening and treatment of chronic hepatitis C virus infection on future hepatocellular carcinoma rates and liver-related mortality

Inputs

Historical (confidence interval)

Year

2013 (uncertainty interval)

HCV infected cases

220720 (153000–286000)

2005

 

 Antibody HCV prevalence

0.4% (0.3% - 0.6%)

  

 Total viraemic cases

151640 (105110–196480)

2005

144000 (103000–174000)

 Viraemic prevalence

0.3% (0.2% - 0.4%)

 

0.3%

 Viraemic rate

68.7%

 

68.7%

HCV diagnosed (Viraemic)

46200

2010

49730

 Viraemic diagnosis rate

30.4%

 

34.5%

 Annual newly diagnosed

5600

2010

5600

New infections

  

3980

 New infection rate (per 100 K)

  

7

Treated

   

 Number treated

5430

2011

5430

 Annual treatment rate

3.6%

 

3.8%